Setipiprant

Setipiprant

SCHEMBL29355657

O=C(O)Cn1c2c(c3cc(F)ccc31)CN(C(=O)c1cccc3ccccc13)CC2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGDR2

The experimentally established mechanism targets of Setipiprant. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTGDR2 known ✓ Q9Y5Y4 19/20 1.00
PTGDR Q13258 6/20 1.00
PTGER2 P43116 5/20 1.00
CYP2C9 P11712 4/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Setipiprant SCHEMBL3089969 1.00 PTGDR2 (1.00) PTGDR2PTGDRPTGER2CYP2C9
Setipiprant SCHEMBL29358337 1.00 PTGDR2 (1.00) PTGDR2PTGDRPTGER2CYP2C9
SCHEMBL3089983 0.89 PTGDR2 (1.00) PTGDR2PTGDRPTGER2CYP2C9
SCHEMBL3083833 0.89 PTGDR2 (1.00) PTGDR2PTGDRPTGER2CYP2C9
SCHEMBL3083273 0.89 PTGDR2 (0.80) PTGDR2PTGDRPTGER2CYP2C9
SCHEMBL3091135 0.89 PTGDR2 (1.00) PTGDR2PTGDRPTGER2CYP2C9
SCHEMBL3081699 0.86 PTGDR2 (1.00) PTGDR2PTGDRPTGER2CYP2C9
SCHEMBL3079230 0.85 PTGDR2 (1.00) PTGDR2PTGDRPTGER2CYP2C9
SCHEMBL3085508 0.85 PTGDR2 (0.73) PTGDR2PTGDRPTGER2CYP2C9
SCHEMBL3083537 0.84 PTGDR2 (0.73) PTGDR2PTGDRPTGER2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3941579-A1 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME AND CRTH2 Amerimmune, LLC (US) 2022-01-26 EP claimed
EP-3941579-A1 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME AND CRTH2 Amerimmune, LLC (US) 2022-01-26 EP disclosed